A Phase 1 Study of the PARP Inhibitor Veliparib in Combination with Temozolomide in Acute Myeloid Leukemia.
PARP抑制剂Veliparib联合替莫唑胺治疗急性髓系白血病的I期研究
期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-16-0984
Gojo Ivana, Beumer Jan H, Pratz Keith W, McDevitt Michael A, Baer Maria R, Blackford Amanda L, Smith B Douglas, Gore Steven D, Carraway Hetty E, Showel Margaret M, Levis Mark J, Dezern Amy E, Gladstone Douglas E, Ji Jiuping Jay, Wang Lihua, Kinders Robert J, Pouquet Marie, Ali-Walbi Ismail, Rudek Michelle A, Poh Weijie, Herman James G, Karnitz Larry M, Kaufmann Scott H, Chen Alice, Karp Judith E
